Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-18 · accession 0001493152-21-029297 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-19 | 2021-11-18 | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $5.82 | +11.2K | 25.6K | +77% | +$65.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-18 | P | A | 11,187 | $5.82 | 25,647 | D | — | — |